Results 161 to 170 of about 61,992 (218)

Bimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials. [PDF]

open access: yesRheumatology (Oxford)
Rudwaleit M   +9 more
europepmc   +1 more source

Biologic and targeted synthetic therapies in ankylosing spondylitis: a pharmacological review. [PDF]

open access: yesFront Pharmacol
Ameer OZ   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy